Ai Mediq is pleased to announce approval of new clinical trial named "Evaluation of clinical efficacy of interval hypoxic-hyperoxic trainings in treatment of patients with reduced ejection fraction of left ventricle (2-3 NYHA)Read More
ReOxy is a new medical device for breathing therapy, that treats a patient with individually dosed levels of reduced-oxygen (hypoxic) gas mixtures throughout the procedure.
Ai Mediq S.A. is a young Health BioMed tech company headquartered in Luxembourg.
Company is focusing on development of therapeutic solutions based on individual cell protection mechanisms management following the concept of personalized medicine. Company developed and sells innovative hypoxic medical devices for treatment and rehabilitation of cardiovascular, neurological diseases and metabolic disorders.Read more
ReOxy breathing therapy device is a device that was developed based on latest developments in medical devices and electronics.
ReOxy is manufactured by Bitmos GmbH and is CE marked and produced in full compliance to 93/42/EEC (Medical Devices Directive – MDD), facilitating high quality and safety of operation.
To help us carry out our mission to provide our customers with innovative solutions that are vital to patient care, we continue to work with a variety of partners to develop and introduce leading edge technologies and products.